Bank of Marin’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-15,344
Closed -$873K 122
2022
Q4
$873K Sell
15,344
-4,189
-21% -$214K 0.82% 39
2022
Q3
$772K Sell
19,533
-9,331
-32% -$412K 0.76% 47
2022
Q2
$1.27M Buy
28,864
+3,538
+14% +$153K 1.12% 25
2022
Q1
$1.01M Buy
25,326
+457
+2% +$16.3K 0.74% 44
2021
Q4
$1M Buy
24,869
+1,223
+5% +$45.7K 0.67% 53
2021
Q3
$962K Buy
23,646
+4,169
+21% +$174K 0.7% 51
2021
Q2
$884K Buy
19,477
+129
+0.7% +$5.71K 0.65% 55
2021
Q1
$807K Buy
19,348
+3,750
+24% +$171K 0.64% 58
2020
Q4
$666K Buy
15,598
+545
+4% +$19.6K 0.56% 64
2020
Q3
$396K Buy
15,053
+172
+1% +$4.79K 0.41% 82
2020
Q2
$399K Buy
+14,881
New +$336K 0.46% 78

Other funds holding HALO

Bank of Marin's HALO Position: Q1 2023 in Review

Bank of Marin sold out of Halozyme (HALO) in Q1 2023, closing a stake of 15,344 shares — an estimated $873K sold.

Bank of Marin first reported a position in HALO in Q2 2020 and held it in 11 quarters. The position peaked at $1.27M in Q2 2022. 386 funds tracked by Wall St. Rank hold HALO as of Q1 2023.

  • Bank of Marin reported no remaining Halozyme position as of Q1 2023 after selling out during the quarter.
  • Bank of Marin sold 15,344 Halozyme shares in Q1 2023, an estimated $873K.
  • Bank of Marin first reported a position in Halozyme in Q2 2020 and held it in 11 quarters.
  • Bank of Marin's Halozyme position peaked at $1.27M in Q2 2022.
  • 386 funds tracked by Wall St. Rank held Halozyme as of Q1 2023.

Based on Bank of Marin's 13F filing for Q1 2023, filed 5 May 2023.